Addition Therapeutics
Addition Therapeutics focuses on developing RNA-only therapeutics using its proprietary PRINT technology. This approach enables the precise insertion of genetic elements at specific safe harbor sites, aiming to transform the field of genetic medicine. They operate within the biotechnology industry and are backed by venture capital. Their innovative methods target gene editing and regulation, potentially offering new solutions in the field of genetic therapies.
Tech Stack (17 technologies)
Frequently Asked Questions
What technologies does Addition Therapeutics use?+
Addition Therapeutics uses 17 technologies including Cookiebot, Elementor, Google Analytics.
What industry is Addition Therapeutics in?+
Addition Therapeutics operates in the Biotechnology industry.
Where is Addition Therapeutics based?+
Addition Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026